Valneva and Pfizer Announce Collaboration to Co-Develop and Commercialize Lyme Disease Vaccine, VLA15 Apr 30, 2020 01:00AM
Merck (MRK) to Acquire Viralytics for $394 Million Feb 21, 2018 06:13AM
Merck and Viralytics Announce Acquisition Agreement, Expanding Merck’s Leading Immuno-Oncology Pipeline Feb 21, 2018 04:00AM